<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id><journal-id journal-id-type="publisher-id">JKMS</journal-id><journal-title-group><journal-title>Journal of Korean Medical Science</journal-title></journal-title-group><issn pub-type="ppub">1011-8934</issn><issn pub-type="epub">1598-6357</issn><publisher><publisher-name>The Korean Academy of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19194567</article-id><article-id pub-id-type="pmc">2633209</article-id><article-id pub-id-type="doi">10.3346/jkms.2009.24.S1.S75</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Clinical Characteristics of Normoalbuminuric Renal Insufficiency in Korean Type 2 Diabetic Patients: A Possible Early Stage Renal Complication</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>An</surname><given-names>Jee Hyun</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cho</surname><given-names>Young Min</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Hyeong Gon</given-names></name><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Jang</surname><given-names>Hak Chul</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Kyong Soo</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Seong Yeon</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Hong Kye</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.</aff><aff id="A2"><label>*</label>Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.</aff><author-notes><corresp>Address for correspondence: Young Min Cho, M.D. Department of Internal Medicine, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-744, Korea. Tel: +82.2-2072-1965, Fax: +82.2-762-5286, <email>ymchomd@snu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>28</day><month>1</month><year>2009</year></pub-date><volume>24</volume><issue>Suppl 1</issue><fpage>S75</fpage><lpage>S81</lpage><history><date date-type="received"><day>15</day><month>7</month><year>2008</year></date><date date-type="accepted"><day>24</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 The Korean Academy of Medical Sciences</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>It has been recently reported that a considerable portion of diabetic patients with renal insufficiency show normoalbuminuria. As little is known about normoalbuminuric renal insufficiency in the Asian population, we examined its prevalence and clinical characteristics in Korean type 2 diabetic patients. We studied 562 patients with type 2 diabetes from Seoul National University Hospital. The estimated glomerular filtration rate (eGFR) was calculated by the Modification of Diet in Renal Disease formula and the degree of albuminuria was evaluated by spot urine albumin-creatinine ratio. Of 562 patients, 151 (26.9%) patients had renal insufficiency (eGFR &#x0003c;60 mL/min/1.73m<sup>2</sup>). Among them, 44 (29.1%) patients had normoalbuminuria. After excluding the patients using renin-angiotensin system (RAS) inhibitors, the prevalence of normoalbuminuric renal insufficiency was 35.3% (18 of 51 patients). Compared with micro- and macroalbuminuric renal insufficiency, normoalbuminuric renal insufficiency was associated with the female predominance, shorter duration of diabetes, lower prevalence of diabetic retinopathy, and lower prevalence of using antihypertensive drugs except RAS inhibitors. The prevalence decreased progressively with an increase in the duration of diabetes and an increase in the severity of retinopathy. Normoalbuminuric renal insufficiency was prevalent in Korean type 2 diabetic patients. The association with a shorter duration of the diabetes and a lower prevalence of retinopathy suggests that it might be an early stage renal complication.</p></abstract><kwd-group><kwd>Normoalbuminuria</kwd><kwd>Renal Insufficiency</kwd><kwd>Diabetes Mellitus</kwd><kwd>Type 2</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>There have been many efforts for the early detection and management of diabetic nephropathy, which is the leading cause of end-stage renal disease (ESRD) (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Microalbuminuria is the initial clinical evidence and an increased albumin excretion rate (AER) is one of the most conventional parameters for the progression of diabetic nephropathy (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Measuring AER as a marker of diabetic nephropathy is based on the natural history of nephropathy in type 1 diabetes (<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B10">10</xref>). However, in type 2 diabetes, there are many other factors that can contribute to renal insufficiency without causing albuminuria, such as atherosclerosis in renal vasculature, cholesterol emboli, and interstitial fibrosis (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>).</p><p>It has been reported that a decline in the renal function of patients with diabetes is not always accompanied by an increased AER (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). About 20-30% of type 2 diabetics with renal insufficiency showed normoalbuminuria (<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B18">18</xref>). In the Third National Health and Nutrition Examination Survey, the prevalence of patients with type 2 diabetes and renal insufficiency in the absence of both albuminuria and retinopathy was about 30% (<xref ref-type="bibr" rid="B12">12</xref>). Compared with the renal insufficiency with albuminuria, the patients with normoalbuminuric renal insufficiency were characterized by female predominance, older age, higher HDL cholesterol, lower prevalence of retinopathy, and possibly better prognosis (<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>). In addition, compared with diabetic patients with normoalbuminuria and normal renal function, patients with normoalbuminuric renal insufficiency had an increased risk of cardiovascular disease and metabolic syndrome (<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>). Therefore, normoalbuminuric renal insufficiency is a distinct entity in diabetic renal complications. However, the natural course and pathophysiologic mechanism of normoalbuminuric renal insufficiency are still elusive.</p><p>It has been shown that ESRD accounts for 10-30% of the deaths in Asian diabetic patients, which clearly contrasts with a &#x0003c;5-10% risk of renal death in Caucasian diabetic patients (<xref ref-type="bibr" rid="B21">21</xref>). Furthermore, a 4-yr follow up study showed that Asian diabetic patients are at high risk of progression to ESRD compared with Caucasian diabetic patients (<xref ref-type="bibr" rid="B22">22</xref>). These data suggest that Asian patients are more susceptible to diabetic renal disease compared with Caucasians. In this regard, the clinical characteristics of normoalbuminuric renal insufficiency in Asian diabetic patients might be different from their Caucasian counterparts.</p><p>We therefore performed a study on the prevalence and clinical characteristics of Korean type 2 diabetic patients with normoalbuminuric renal insufficiency and examined its relations to renin-angiotensin system (RAS) inhibitors, diabetic retinopathy, and the duration of the diabetes.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Study population</title><p>We studied 562 randomly selected patients from the Diabetes Clinic at Seoul National University Hospital from January to December, 2006, who were diagnosed with type 2 diabetes. Excluded from this study were those patients with anti-GAD antibodies; those who started insulin therapy within the first year after diagnosis; those with a urinary tract infection, hematuria, or other causes of renal insufficiency; those with cardiac or hepatic failure; and those with a severe intercurrent illness, including malignancy. The Institutional Review Board of the Clinical Research Institute in Seoul National University Hospital approved the study protocol.</p></sec><sec><title>Estimation of glomerular filtration rate (GFR)</title><p>We calculated the GFR with the Modification of Diet in Renal Disease (MDRD) formula (<xref ref-type="bibr" rid="B23">23</xref>) and defined renal insufficiency as an estimated GFR (eGFR) of less than 60 mL/min per 1.73 m<sup>2</sup> body surface area (BSA), which corresponded to the National Kidney Foundation Kidney Dialysis Outcomes Quality Initiative guideline (<xref ref-type="bibr" rid="B24">24</xref>).</p></sec><sec><title>Quantification of albuminuria</title><p>We measured the degree of albuminuria with spot tests of the urine albumin-creatinine ratio (ACR). Urinary albumin levels were measured by turbitimer assay (A&#x00026;T 502X, A&#x00026;T, Tokyo, Japan) and urine creatinine levels were measured by the Jaffe method (Hitachi 7170, Hitachi, Tokyo, Japan).</p><p>We used sex-specific ACR cut points to define micro- and macroalbuminuria (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Microalbuminuria was defined as an ACR from 17 to 250 &#x000b5;g/mg for males and from 25 to 355 &#x000b5;g/mg for females. Macroalbuminuria was defined as an ACR over 250 &#x000b5;g/mg and over 355 &#x000b5;g/mg for males and females, respectively. Albuminuria denotes the presence of micro- or macroalbuminuria.</p></sec><sec><title>Assessment of covariates</title><p>Questionnaires and review of the patients' medical records were used to evaluate the history of stroke, coronary artery disease, and peripheral vascular disease. Hypertension was defined as a systolic blood pressure over 140 mmHg or a diastolic blood pressure over 90 mmHg, or the fact that the patient was taking antihypertensive medications. Drug histories in relation to anti-hypertensive agents and lipid lowering agents were also evaluated. Fasting plasma glucose, HbA1c, serum creatinine, blood urea nitrogen (BUN), serum albumin, total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol concentrations were measured. Diabetic retinopathy was evaluated by direct fundus examination and was graded according to the modified Airlie House Classification (<xref ref-type="bibr" rid="B27">27</xref>).</p></sec><sec><title>Statistical analysis</title><p>All continuous variables with normal distributions were expressed as means&#x000b1;SD, while variables with skewed distributions were expressed as medians with a range. Variables not normally distributed were logarithmically transformed before statistical analysis. The results of categorical data are expressed as percentages. Student's t-test and ANOVA were used to compare the continuous variables between groups and the chi-square test was used for categorical variables. The <italic>p</italic> value for a trend was evaluated by the Mantel-Haenszel chi-square test. A level of <italic>p</italic>&#x0003c;0.05 was considered statistically significant. All data were analyzed using SPSS for Windows (SPSS Inc., Chicago, IL, U.S.A.).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 562 patients were enrolled in this study. Their mean age was 59&#x000b1;10 yr; the mean duration of diabetes was 8.0&#x000b1;7.4 yr; and their mean eGFR was 71.3&#x000b1;11.5 mL/min per 1.73m<sup>2</sup>. There was a significant inverse correlation between ACR and eGFR (r=-0.651, <italic>p</italic>&#x0003c;0.001) (<xref ref-type="fig" rid="F1">Fig. 1</xref>). In the patients with eGFR &#x0003c;60 mL/min/1.73m<sup>2</sup>, the coefficient of correlation between ACR and eGFR slightly decreased (r=-0.552, <italic>p</italic>&#x0003c;0.001).</p><p>Among 562 patients, 151 (26.9%) had renal insufficiency, defined as an eGFR &#x0003c;60 mL/min per 1.73 m<sup>2</sup>. Among these, the prevalence of normo-, micro-, and macroalbuminuric patients was 29.1% (n=44), 33.1% (n=50), and 37.8% (n=57), respectively. After excluding the patients using RAS inhibitors (angiotensin converting enzyme inhibitors or angiotensin II receptor blockers), the number of patients with renal insufficiency was 51 and the prevalence of normo-, micro-, and macroalbuminuric renal insufficiency was 35.3% (n=18), 41.2% (n=21), and 23.5% (n=12), respectively (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p>The characteristics of the 151 patients with an eGFR &#x0003c;60 mL/min per 1.73 m<sup>2</sup> stratified according to their ACR, as shown in <xref ref-type="table" rid="T2">Table 2</xref>. Compared with microalbuminuric renal insufficiency, normoalbuminuric renal insufficiency was associated with female predominance, shorter duration of diabetes, lower BUN and creatinine, higher eGFR, and lower HbA1c. In addition, patients with normoalbuminuric renal insufficiency had a lower prevalence of hypertension and retinopathy, and a lower prevalence of using anti-hypertensive drugs except RAS inhibitors. Among them, female predominance, lower HbA1c, shorter duration of diabetes, lower prevalence of hypertension and retinopathy, and a lower prevalence of using antihypertensive drugs other than RAS inhibitors were still significant, even after adjusting for their eGFR. When the patients using RAS inhibitors were excluded, we obtained similar results (data not shown). Next, we compared the characteristics of the patients with normoalbuminuric renal insufficiency with those who had macroalbuminuric renal insufficiency. The results showed very similar trends to those of the comparison between normo- and microalbuminuric renal insufficiency, except for HbA1c, which was comparable between the two groups. Finally, we found that female predominance, shorter duration of diabetes, lower prevalence of hypertension and retinopathy, and a lower prevalence of using antihypertensive drugs except RAS inhibitors showed significant trends across the degree of albuminuria.</p><p><xref ref-type="table" rid="T3">Table 3</xref> compares the clinical characteristics of 349 patients with normoalbuminuria according to their eGFR. The patients with normoalbuminuric renal insufficiency (n=44, 12.6%) were older, more likely to be female, had a higher prevalence of using RAS inhibitors and statins, and a higher prevalence of coronary artery disease. The patients with normoalbuminuric renal insufficiency, who were not taking RAS inhibitors or statins, showed similar results but they additionally showed higher triglyceride levels (1.83 [0.59-8.20] vs. 1.69 [0.65-6.53] mM/L, <italic>p</italic>=0.03; expressed as a median [range]) and lower HDL-cholesterol levels (1.01&#x000b1;0.23 vs. 1.24&#x000b1;0.28 mM/L, <italic>p</italic>=0.02) compared to their counterparts with normal renal function.</p><p>We evaluated the trend of changes in the prevalence of normo-, micro-, and macroalbuminuric renal insufficiency along with the duration of the diabetes. The prevalence of normoalbuminuria decreased progressively, whereas the prevalence of macroalbuminuria increased with an increase in the duration of diabetes (Mantel-Haenszel &#x003c7;<sup>2</sup> test, <italic>p</italic> for trend &#x0003c;0.001) (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p><p><xref ref-type="table" rid="T4">Table 4</xref> shows the prevalence of the respective grade of retinopathy according to the AER status of the patients with renal insufficiency. The retinopathy and albuminuria were both absent in 37 of the 151 (24.5%) patients. In the normoalbuminuric renal insufficiency group, most of the patients (37 of 44 patients, 84.1%) had no retinopathy. The prevalence and severity of retinopathy were markedly and progressively increased in the micro- and macroalbuminuria groups (Mantel-Haenszel chi-square test, <italic>p</italic> for trend &#x0003c;0.001).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Among the Korean patients with type 2 diabetes and renal insufficiency, the prevalence of normoalbuminuria was 29.1% (35.3% in those not using RAS inhibitors). Even after adjusting for their eGFR, normoalbuminuric renal insufficiency was associated with female predominance, lower HbA1c, shorter duration of diabetes, lower prevalence of hypertension and retinopathy, and a lower prevalence of using antihypertensive drugs except RAS inhibitors compared with microalbuminuric renal insufficiency. These results are largely similar to those from Caucasian studies (<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>). The characteristics of a shorter duration of the diabetes and a lower prevalence of retinopathy found in this study suggest that normoalbuminuric renal insufficiency might be an earlier stage of renal insufficiency compared with microalbuminuric renal insufficiency. This is further supported by the results that the prevalence of normoalbuminuric renal insufficiency decreased with an increase in the duration of the diabetes and with the advanced stage of retinopathy. Thus, it might be speculated that some type 2 diabetic patients might face renal insufficiency without albuminuria and may then progress to microalbuminuric and macroalbuminuric renal insufficiency as the duration of type 2 diabetes increases. However, there are reports showing that normoalbuminuric renal insufficiency was not associated with a lower prevalence of retinopathy (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Furthermore, Rigalleau et al. (<xref ref-type="bibr" rid="B17">17</xref>) reported that diabetic patients with normoalbuminuric renal insufficiency showed stable AER over 38 months and had a low risk for the progression to ESRD or death. Therefore, to support our hypothesis that normoalbuminuric renal insufficiency might be an earlier stage of diabetic renal complication, we need a prospective study including looking into the change of renal pathology.</p><p>In the next step, we examined whether there was any difference in the clinical characteristics of normoalbuminuric patients according to their eGFR. Compared with the patients with normoalbuminuria in the absence of renal insufficiency, those with normoalbuminuric renal insufficiency were older, more likely to be female, had a higher prevalence of using RAS inhibitors and statins, and a higher prevalence of coronary artery disease. The higher prevalence of coronary artery disease suggests that other atherosclerotic diseases involving the renal vasculature might be responsible for the decreased renal function in the absence of albuminuria. In this regard, a recent report (<xref ref-type="bibr" rid="B18">18</xref>) also showed that normoalbuminuric renal insufficiency was associated with metabolic syndrome. However, MacIsaac et al. (<xref ref-type="bibr" rid="B16">16</xref>) found that patients with type 2 diabetes and reduced GFR had similar degrees of intrarenal vascular disease, assessed by the intrarenal arterial resistance index. Therefore, at this time, the mechanism of normoalbuminuric renal insufficiency still remains elusive. Interestingly, genetic susceptibility might play a role in the development of normoalbuminuric renal insufficiency. It has been reported that polymorphisms of the protein kinase C-&#x003b2; gene (PRKCB1) were associated with diabetic nephropathy that did not lead to albuminuria in Japanese patients (<xref ref-type="bibr" rid="B28">28</xref>).</p><p>A female predilection for normoalbuminuric renal insufficiency has been noted in many other previous studies (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>), but the reason for this association is unknown. In this study, the patients with normoalbuminuric renal insufficiency were more likely to be females over 50 (odds ratio [OR] and 95% confidence interval [CI] was 3.08 [1.15-4.13], <italic>p</italic>=0.017), while we could not find this age effect in male subjects (OR and 95% CI was 1.38 [0.48-3.26], <italic>p</italic>=0.646) (data not shown in the Results). Therefore, the pathogenesis of normoalbuminuric renal insufficiency might be affected by the hormonal change that occurs around menopause.</p><p>There were several limitations in this study. First, owing to the cross-sectional design it was difficult to clarify the causal relationship between the risk factors and the natural course of the normoalbuminuric renal insufficiency. Second, the eGFR might not reflect the actual GFR of our study population, since the MDRD study included very few Asians (<xref ref-type="bibr" rid="B29">29</xref>). Third, the assessment of AER with a single specimen might not exactly estimate the number of normoalbuminuric renal insufficiency. Finally, the number of the patients with renal insufficiency not taking RAS inhibitors was somewhat small. Therefore, a further study including sufficient number of patients in this category is necessary.</p><p>In conclusion, normoalbuminuric renal insufficiency was prevalent in type 2 diabetic Korean patients and the clinical characteristics were largely similar to those seen in previous studies. The association with a shorter duration of the diabetes and a lower prevalence of retinopathy suggests that normoalbuminuric renal insufficiency might be an early stage renal complication in Korean type 2 diabetic patients.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p>This study was supported by a grant from the <funding-source>Korea Health 21 R &#x00026; D Project</funding-source>, <funding-source>Ministry of Health &#x00026; Welfare, Republic of Korea</funding-source> (<award-id>00-PJ3-PG6-GN07-001</award-id>).</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>AJ</given-names></name><name><surname>Kasiske</surname><given-names>B</given-names></name><name><surname>Herzog</surname><given-names>C</given-names></name><name><surname>Chavers</surname><given-names>B</given-names></name><name><surname>Foley</surname><given-names>R</given-names></name><name><surname>Gilbertson</surname><given-names>D</given-names></name><name><surname>Grimm</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Louis</surname><given-names>T</given-names></name><name><surname>Manning</surname><given-names>W</given-names></name><name><surname>Matas</surname><given-names>A</given-names></name><name><surname>McBean</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>St Peter</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Snyder</surname><given-names>J</given-names></name><name><surname>Solid</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Weinhandl</surname><given-names>E</given-names></name><name><surname>Arko</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Dalleska</surname><given-names>F</given-names></name><name><surname>Daniels</surname><given-names>F</given-names></name><name><surname>Dunning</surname><given-names>S</given-names></name><name><surname>Ebben</surname><given-names>J</given-names></name><name><surname>Frazier</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Sheets</surname><given-names>D</given-names></name><name><surname>Forrest</surname><given-names>B</given-names></name><name><surname>Berrini</surname><given-names>D</given-names></name><name><surname>Constantini</surname><given-names>E</given-names></name><name><surname>Everson</surname><given-names>S</given-names></name><name><surname>Frederick</surname><given-names>P</given-names></name><name><surname>Eggers</surname><given-names>P</given-names></name><name><surname>Agodoa</surname><given-names>L</given-names></name></person-group><article-title>Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States</article-title><source>Am J Kidney Dis</source><year>2005</year><volume>45</volume><issue>1 Suppl 1</issue><fpage>A5</fpage><lpage>A7</lpage><fpage>S1</fpage><lpage>S280</lpage><pub-id pub-id-type="pmid">15640975</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname><given-names>E</given-names></name><name><surname>Rychlik</surname><given-names>I</given-names></name><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Halimi</surname><given-names>S</given-names></name></person-group><article-title>End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions</article-title><source>Am J Kidney Dis</source><year>1999</year><volume>34</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">10561134</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retnakaran</surname><given-names>R</given-names></name><name><surname>Cull</surname><given-names>CA</given-names></name><name><surname>Thorne</surname><given-names>KI</given-names></name><name><surname>Adler</surname><given-names>AI</given-names></name><name><surname>Holman</surname><given-names>RR</given-names></name></person-group><article-title>Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>1832</fpage><lpage>1839</lpage><pub-id pub-id-type="pmid">16731850</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>CE</given-names></name></person-group><article-title>Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><fpage>263</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">10096778</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>CE</given-names></name><name><surname>Christensen</surname><given-names>CK</given-names></name></person-group><article-title>Predicting diabetic nephropathy in insulin-dependent patients</article-title><source>N Engl J Med</source><year>1984</year><volume>311</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">6738599</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parving</surname><given-names>HH</given-names></name><name><surname>Oxenboll</surname><given-names>B</given-names></name><name><surname>Svendsen</surname><given-names>PA</given-names></name><name><surname>Christiansen</surname><given-names>JS</given-names></name><name><surname>Andersen</surname><given-names>AR</given-names></name></person-group><article-title>Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion</article-title><source>Acta Endocrinol (Copenh)</source><year>1982</year><volume>100</volume><fpage>550</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">6812342</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovind</surname><given-names>P</given-names></name><name><surname>Tarnow</surname><given-names>L</given-names></name><name><surname>Rossing</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>BR</given-names></name><name><surname>Graae</surname><given-names>M</given-names></name><name><surname>Torp</surname><given-names>I</given-names></name><name><surname>Binder</surname><given-names>C</given-names></name><name><surname>Parving</surname><given-names>HH</given-names></name></person-group><article-title>Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study</article-title><source>BMJ</source><year>2004</year><volume>328</volume><fpage>1105</fpage><pub-id pub-id-type="pmid">15096438</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsblom</surname><given-names>CM</given-names></name><name><surname>Groop</surname><given-names>PH</given-names></name><name><surname>Ekstrand</surname><given-names>A</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name></person-group><article-title>Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration</article-title><source>BMJ</source><year>1992</year><volume>305</volume><fpage>1051</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">1467683</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossing</surname><given-names>P</given-names></name><name><surname>Hougaard</surname><given-names>P</given-names></name><name><surname>Parving</surname><given-names>HH</given-names></name></person-group><article-title>Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study</article-title><source>Kidney Int</source><year>2005</year><volume>68</volume><fpage>1446</fpage><lpage>1450</lpage><pub-id pub-id-type="pmid">16164620</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorgino</surname><given-names>F</given-names></name><name><surname>Laviola</surname><given-names>L</given-names></name><name><surname>Cavallo Perin</surname><given-names>P</given-names></name><name><surname>Solnica</surname><given-names>B</given-names></name><name><surname>Fuller</surname><given-names>J</given-names></name><name><surname>Chaturvedi</surname><given-names>N</given-names></name></person-group><article-title>Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study</article-title><source>Diabetologia</source><year>2004</year><volume>47</volume><fpage>1020</fpage><lpage>1028</lpage><pub-id pub-id-type="pmid">15170497</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rychlik</surname><given-names>I</given-names></name><name><surname>Jancova</surname><given-names>E</given-names></name><name><surname>Tesar</surname><given-names>V</given-names></name><name><surname>Kolsky</surname><given-names>A</given-names></name><name><surname>Lacha</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>J</given-names></name><name><surname>Stejskalova</surname><given-names>A</given-names></name><name><surname>Dusek</surname><given-names>J</given-names></name><name><surname>Herout</surname><given-names>V</given-names></name></person-group><article-title>The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000</article-title><source>Nephrol Dial Transplant</source><year>2004</year><volume>19</volume><fpage>3040</fpage><lpage>3049</lpage><pub-id pub-id-type="pmid">15507479</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>HJ</given-names></name><name><surname>Nguyen</surname><given-names>QD</given-names></name><name><surname>Curhan</surname><given-names>G</given-names></name><name><surname>Hsu</surname><given-names>CY</given-names></name></person-group><article-title>Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>3273</fpage><lpage>3277</lpage><pub-id pub-id-type="pmid">12824208</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>PH</given-names></name><name><surname>Steffes</surname><given-names>MW</given-names></name><name><surname>Mauer</surname><given-names>SM</given-names></name></person-group><article-title>Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion</article-title><source>Diabetes</source><year>1992</year><volume>41</volume><fpage>581</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">1568527</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsalamandris</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>TJ</given-names></name><name><surname>Gilbert</surname><given-names>RE</given-names></name><name><surname>Sinha</surname><given-names>A</given-names></name><name><surname>Panagiotopoulos</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name><name><surname>Jerums</surname><given-names>G</given-names></name></person-group><article-title>Progressive decline in renal function in diabetic patients with and without albuminuria</article-title><source>Diabetes</source><year>1994</year><volume>43</volume><fpage>649</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">8168641</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacIsaac</surname><given-names>RJ</given-names></name><name><surname>Tsalamandris</surname><given-names>C</given-names></name><name><surname>Panagiotopoulos</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>McNeil</surname><given-names>KJ</given-names></name><name><surname>Jerums</surname><given-names>G</given-names></name></person-group><article-title>Nonalbuminuric renal insufficiency in type 2 diabetes</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">14693989</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacIsaac</surname><given-names>RJ</given-names></name><name><surname>Panagiotopoulos</surname><given-names>S</given-names></name><name><surname>McNeil</surname><given-names>KJ</given-names></name><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>Tsalamandris</surname><given-names>C</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Matthews</surname><given-names>PG</given-names></name><name><surname>Thomas</surname><given-names>MC</given-names></name><name><surname>Power</surname><given-names>DA</given-names></name><name><surname>Jerums</surname><given-names>G</given-names></name></person-group><article-title>Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>1560</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">16801579</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigalleau</surname><given-names>V</given-names></name><name><surname>Lasseur</surname><given-names>C</given-names></name><name><surname>Raffaitin</surname><given-names>C</given-names></name><name><surname>Beauvieux</surname><given-names>MC</given-names></name><name><surname>Barthe</surname><given-names>N</given-names></name><name><surname>Chauveau</surname><given-names>P</given-names></name><name><surname>Combe</surname><given-names>C</given-names></name><name><surname>Gin</surname><given-names>H</given-names></name></person-group><article-title>Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>2034</fpage><lpage>2039</lpage><pub-id pub-id-type="pmid">17485574</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>CK</given-names></name><name><surname>Leitao</surname><given-names>CB</given-names></name><name><surname>Pinto</surname><given-names>LC</given-names></name><name><surname>Silveiro</surname><given-names>SP</given-names></name><name><surname>Gross</surname><given-names>JL</given-names></name><name><surname>Canani</surname><given-names>LH</given-names></name></person-group><article-title>Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>1998</fpage><lpage>2000</lpage><pub-id pub-id-type="pmid">17468344</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobler</surname><given-names>H</given-names></name><name><surname>Zornitzki</surname><given-names>T</given-names></name><name><surname>Vered</surname><given-names>S</given-names></name><name><surname>Oettinger</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Caspi</surname><given-names>A</given-names></name><name><surname>Faraggi</surname><given-names>D</given-names></name><name><surname>Livschitz</surname><given-names>S</given-names></name></person-group><article-title>Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>2142</fpage><lpage>2148</lpage><pub-id pub-id-type="pmid">15582311</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nag</surname><given-names>S</given-names></name><name><surname>Bilous</surname><given-names>R</given-names></name><name><surname>Kelly</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Roper</surname><given-names>N</given-names></name><name><surname>Connolly</surname><given-names>V</given-names></name></person-group><article-title>All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study</article-title><source>Diabet Med</source><year>2007</year><volume>24</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">17227319</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrish</surname><given-names>NJ</given-names></name><name><surname>Wang</surname><given-names>SL</given-names></name><name><surname>Stevens</surname><given-names>LK</given-names></name><name><surname>Fuller</surname><given-names>JH</given-names></name><name><surname>Keen</surname><given-names>H</given-names></name></person-group><article-title>Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes</article-title><source>Diabetologia</source><year>2001</year><volume>44</volume><issue>Suppl 2</issue><fpage>S14</fpage><lpage>S21</lpage><pub-id pub-id-type="pmid">11587045</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karter</surname><given-names>AJ</given-names></name><name><surname>Ferrara</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Moffet</surname><given-names>HH</given-names></name><name><surname>Ackerson</surname><given-names>LM</given-names></name><name><surname>Selby</surname><given-names>JV</given-names></name></person-group><article-title>Ethnic disparities in diabetic complications in an insured population</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>2519</fpage><lpage>2527</lpage><pub-id pub-id-type="pmid">12020332</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Bosch</surname><given-names>JP</given-names></name><name><surname>Lewis</surname><given-names>JB</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Rogers</surname><given-names>N</given-names></name><name><surname>Roth</surname><given-names>D</given-names></name></person-group><article-title>A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group</article-title><source>Ann Intern Med</source><year>1999</year><volume>130</volume><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">10075613</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><collab>KDOQI</collab><article-title>KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease</article-title><source>Am J Kidney Dis</source><year>2007</year><volume>49</volume><issue>2 Suppl 2</issue><fpage>S12</fpage><lpage>S154</lpage><pub-id pub-id-type="pmid">17276798</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattix</surname><given-names>HJ</given-names></name><name><surname>Hsu</surname><given-names>CY</given-names></name><name><surname>Shaykevich</surname><given-names>S</given-names></name><name><surname>Curhan</surname><given-names>G</given-names></name></person-group><article-title>Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>1034</fpage><lpage>1039</lpage><pub-id pub-id-type="pmid">11912263</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warram</surname><given-names>JH</given-names></name><name><surname>Gearin</surname><given-names>G</given-names></name><name><surname>Laffel</surname><given-names>L</given-names></name><name><surname>Krolewski</surname><given-names>AS</given-names></name></person-group><article-title>Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio</article-title><source>J Am Soc Nephrol</source><year>1996</year><volume>7</volume><fpage>930</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">8793803</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><article-title>Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy</article-title><source>Invest Ophthalmol Vis Sci</source><year>1981</year><volume>21</volume><fpage>1</fpage><lpage>226</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>S</given-names></name><name><surname>Haneda</surname><given-names>M</given-names></name><name><surname>Sugimoto</surname><given-names>T</given-names></name><name><surname>Isono</surname><given-names>M</given-names></name><name><surname>Isshiki</surname><given-names>K</given-names></name><name><surname>Kashiwagi</surname><given-names>A</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name></person-group><article-title>Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>864</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">16567829</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poggio</surname><given-names>ED</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Van Lente</surname><given-names>F</given-names></name><name><surname>Hall</surname><given-names>PM</given-names></name></person-group><article-title>Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">15615823</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Inverse linear relationship between albumin-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR).</p></caption><graphic xlink:href="jkms-24-S75-g001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p>The relationship between the degree of urinary albumin excretion and the duration of diabetes in type 2 diabetic patients with renal insufficiency. <italic>p</italic> for trend &#x0003c;0.001 by Mantel-Haenszel &#x003c7;<sup>2</sup> test.</p></caption><graphic xlink:href="jkms-24-S75-g002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The prevalence of type 2 diabetic patients classified according to estimated glomerular filtration rate (eGFR) and albumin excretion rate (AER) status</p></caption><graphic xlink:href="jkms-24-S75-i001"/><table-wrap-foot><fn><p>Data are expressed as n (%).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Clinical and laboratory characteristics of type 2 diabetic patients with renal insufficiency according to albumin excretion ratio (AER) status</p></caption><graphic xlink:href="jkms-24-S75-i002"/><table-wrap-foot><fn><p>Data are means&#x000b1;SD or n (%) unless otherwise indicated. <sup>*</sup>means <italic>p</italic>&#x0003c;0.05 vs. the normoalbuminuric group; <sup>&#x02020;</sup>means <italic>p</italic>&#x0003c;0.05 vs. the normoalbuminuric group after exclusion of the patients using renin-angiotensin system inhibitors and after adjustment for GFR. <italic>p</italic> value<sup>1</sup> means the significance of the difference between the normo- and micro-albuminuric groups. <italic>p</italic> value<sup>2</sup> means the significance for the trend that follows the normo-, micro- and macroalbuminuric groups.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Clinical and laboratory characteristics of type 2 diabetic patients with normoalbuminuria according to eGFR</p></caption><graphic xlink:href="jkms-24-S75-i003"/><table-wrap-foot><fn><p>Data are means&#x000b1;SD or n (%) unless otherwise indicated. <sup>*</sup>means <italic>p</italic>&#x0003c;0.05 after exclusion of the patients using renin-angiotensin system inhibitors and statins.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>The prevalence of retinopathy in type 2 diabetic patients with renal insufficiency</p></caption><graphic xlink:href="jkms-24-S75-i004"/><table-wrap-foot><fn><p>Data are expressed as n (%). <italic>p</italic> for trend &#x0003c;0.001 by Mantel-Haenszel chi-square test.</p></fn></table-wrap-foot></table-wrap></floats-group></article>